Molecular Evolutionary Analyses of the Pseudomonas-Derived Cephalosporinase Gene
暂无分享,去创建一个
A. Ryo | H. Tomita | H. Ishii | Kaori Okayama | Taisei Ishioka | R. Kimura | S. Hirai | T. Shirai | Hirokazu Kimura | Norika Nagasawa | Mao Akagawa | Mitsuru Sada | Manami Ishii | Miho Makino | Ayaka Arai | Shinichiro Hirai
[1] S. Molin,et al. Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams , 2022, mBio.
[2] A. Ryo,et al. Molecular Evolution of the Pseudomonas aeruginosa DNA Gyrase gyrA Gene , 2022, Microorganisms.
[3] A. Philippon,et al. Class C β-Lactamases: Molecular Characteristics , 2022, Clinical microbiology reviews.
[4] M. Mukherjee,et al. Impact of Mutation on the Structural Stability and the Conformational Landscape of Inhibitor-Resistant TEM β-Lactamase: A High-Performance Molecular Dynamics Simulation Study. , 2021, The journal of physical chemistry. B.
[5] Douglas E. V. Pires,et al. A structural biology community assessment of AlphaFold2 applications , 2021, bioRxiv.
[6] C. Schiffer,et al. Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. , 2021, Chemical reviews.
[7] P. Agarwal,et al. Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics , 2021, bioRxiv.
[8] J. Frère,et al. A Standard Numbering Scheme for Class C β-Lactamases , 2019, Antimicrobial Agents and Chemotherapy.
[9] R. Gothalwal,et al. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review , 2019, Genes & diseases.
[10] M. Wilcox,et al. Effect of fluoroquinolone resistance mutation Thr-82→Ile on Clostridioides difficile fitness , 2018, The Journal of antimicrobial chemotherapy.
[11] B. Glick,et al. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. , 2019, Biotechnology advances.
[12] M. Suchard,et al. Posterior summarisation in Bayesian phylogenetics using Tracer , 2022 .
[13] B. Kreiswirth,et al. Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation , 2017, Antimicrobial Agents and Chemotherapy.
[14] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.
[15] Sudhir Kumar,et al. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. , 2016, Molecular biology and evolution.
[16] I. Broutin,et al. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins , 2015, Antimicrobial Agents and Chemotherapy.
[17] F. Eftekhar,et al. Prevalence of Extended-Spectrum and Metallo β-Lactamase Production in AmpC β-Lactamase Producing Pseudomonas aeruginosa Isolates From Burns , 2014, Jundishapur journal of microbiology.
[18] P. Ross,et al. Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance , 2014, Antimicrobial Agents and Chemotherapy.
[19] Dong Xie,et al. BEAST 2: A Software Platform for Bayesian Evolutionary Analysis , 2014, PLoS Comput. Biol..
[20] A. Bordogna,et al. Defining the limits of homology modeling in information‐driven protein docking , 2013, Proteins.
[21] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[22] Wai Lok Sibon Li,et al. Accurate model selection of relaxed molecular clocks in bayesian phylogenetics. , 2012, Molecular biology and evolution.
[23] Olivier Fisette,et al. Molecular dynamics of class A β-lactamases-effects of substrate binding. , 2012, Biophysical journal.
[24] A. Oliver,et al. Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones , 2012, Antimicrobial Agents and Chemotherapy.
[25] M. Suchard,et al. Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. , 2012, Molecular biology and evolution.
[26] Ramón Doallo,et al. CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics , 2012, Nature Methods.
[27] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[28] K. Bush,et al. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. , 2011, Annual review of microbiology.
[29] M. Silby,et al. Pseudomonas genomes: diverse and adaptable. , 2011, FEMS microbiology reviews.
[30] V. Tam,et al. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes , 2010, Expert review of pharmacoeconomics & outcomes research.
[31] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[32] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[33] P. Nordmann,et al. Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa , 2009, Antimicrobial Agents and Chemotherapy.
[34] Tatiana Giraud,et al. Rapidly evolving genes in pathogens: methods for detecting positive selection and examples among fungi, bacteria, viruses and protists. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[35] A. Oliver,et al. β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein , 2009, PLoS pathogens.
[36] George A. Jacoby,et al. AmpC β-Lactamases , 2009, Clinical Microbiology Reviews.
[37] A. Shorr. Epidemiology of staphylococcal resistance. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] J. Quinn,et al. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[39] Mathieu Fourment,et al. PATRISTIC: a program for calculating patristic distances and graphically comparing the components of genetic change , 2006, BMC Evolutionary Biology.
[40] R. MacLaren,et al. National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002 , 2004, Antimicrobial Agents and Chemotherapy.
[41] E. Bouza,et al. Catheter-related infections: diagnosis and intravascular treatment. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[42] George A. Jacoby,et al. Plasmid-Determined AmpC-Type β-Lactamases , 2002, Antimicrobial Agents and Chemotherapy.
[43] R. Ramphal,et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] B. Tümmler,et al. Sequence Diversity of Pseudomonas aeruginosa: Impact on Population Structure and Genome Evolution , 2000, Journal of bacteriology.
[45] N. Masuda,et al. Interplay between Chromosomal β-Lactamase and the MexAB-OprM Efflux System in Intrinsic Resistance to β-Lactams inPseudomonas aeruginosa , 1999, Antimicrobial Agents and Chemotherapy.
[46] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[47] J. Frère,et al. Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] F. J. DeOrio,et al. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels , 1989, Antimicrobial Agents and Chemotherapy.